Khalid Salaita has been named Samuel Candler Dobbs Professor of Chemistry, one of the highest honors that Emory bestows upon a member of its faculty.Continue readingKhalid Salaita appointed to distinguished professorship
Molnupiravir is currently being developed by Merck & Co. Inc. in collaboration with Ridgeback Biotherapeutics, which licensed the drug from DRIVE (founded by Emory chemist Dennis Liotta) in 2020. It could be the first oral antiviral medicine to treat COVID-19. Continue readingMolnupiravir and Drug Development at Emory
Bill Wuest, a chemistry professor at Emory University, says the hot job market in pharmaceutical chemistry contrasts with a dearth of jobs in academia. And even some of those who have jobs in academia are making a move. Read more.Continue readingBill Wuest discusses biotech job market in C&EN
Bowman Group alumn John Mancini is profiled in the popular “Vows” column in the New York Times.Continue readingBowman Group alum featured in NYT “Vows”
We are excited to welcome our entering graduate cohort of 25!Continue readingWelcome to our new graduate cohort!
The Royal Society of Chemistry has recognized #BlackInChem for the creation of a platform to amplify Black voices, celebrate Black excellence in chemistry, and build a global community of Black chemists and their allies.Continue reading#BlackInChem receives 2021 RSC Prize
Katherine M. Davis has been named a 2021 Beckman Young Investigator for her research using X-rays to shine light on the synergy between metalloenzyme structure and electronics.Continue readingKate Davis named 2021 Beckman Young Investigator
DRIVE seeks disease-fighting solutions via a different paradigm than big pharmaceutical industry. The New York Times features an opinion piece titled “In the Race for a Covid-19 Pill, a Little Lab Plays a Big Role.”Continue readingLiotta Group and DRIVE featured in New York Times